These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 9759624)
1. A heparin-coated circuit maintains platelet aggregability in response to shear stress in an in vitro model of cardiopulmonary bypass. Hioki I; Nishikawa M; Onoda K; Shimono T; Shimpo H; Tanaka K; Suzuki Y; Shiku H; Ikeda Y; Yada I Thromb Haemost; 1998 Sep; 80(3):437-42. PubMed ID: 9759624 [TBL] [Abstract][Full Text] [Related]
2. Heparin influences human platelet behavior in cardiac surgery with or without cardiopulmonary bypass. Laga S; Bollen H; Arnout J; Hoylaerts M; Meyns B Artif Organs; 2005 Jul; 29(7):541-6. PubMed ID: 15982282 [TBL] [Abstract][Full Text] [Related]
3. Comparative studies of glycoprotein Ib in heparin coated and nonheparin coated extracorporeal circulation circuits. Hioki I; Yada I; Nishikawa M; Shomura Y; Cruz BP; Onoda K; Tani K; Shimono T; Shinpo H ASAIO J; 1998; 44(5):M397-400. PubMed ID: 9804459 [TBL] [Abstract][Full Text] [Related]
4. A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist. Wang WJ; Huang TF Thromb Haemost; 2001 Oct; 86(4):1077-86. PubMed ID: 11686327 [TBL] [Abstract][Full Text] [Related]
5. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass. Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115 [TBL] [Abstract][Full Text] [Related]
6. Specific inhibiting effects of Ilexonin A on von Willebrand factor-dependent platelet aggregation under high shear rate. Li M; Wu WK; Liu L; Liao FL; Shinohara Y; Handa S; Goto S Chin Med J (Engl); 2004 Feb; 117(2):241-6. PubMed ID: 14975210 [TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a silicone coated hollow fiber oxygenator. Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143 [TBL] [Abstract][Full Text] [Related]
8. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V. Kang M; Wilson L; Kermode JC Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030 [TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits. Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955 [TBL] [Abstract][Full Text] [Related]
10. Red blood cell aggregation during cardiopulmonary bypass: a pathogenic cofactor in endothelial cell activation? Morariu AM; Gu YJ; Huet RC; Siemons WA; Rakhorst G; Oeveren WV Eur J Cardiothorac Surg; 2004 Nov; 26(5):939-46. PubMed ID: 15519186 [TBL] [Abstract][Full Text] [Related]
11. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass. Muriithi EW; Belcher PR; Rao JN; Chaudhry MA; Nicol D; Wheatley DJ J Thorac Cardiovasc Surg; 2000 Sep; 120(3):538-43. PubMed ID: 10962416 [TBL] [Abstract][Full Text] [Related]